Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company ProMIS Neurosciences Inc.
Description mAb against disease specific epitopes (DSEs) on misfolded Fas receptor
Molecular Target Fas receptor (CD95)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationMelanoma
Indication DetailsTreat melanoma
Regulatory Designation
PartnerApexigen Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today